Would screening for lung cancer benefit 75- to 84-year-old residents of the United States?


BACKGROUND:The National Lung Screening Trial demonstrated that screening for lung cancer improved overall survival (OS) and reduced lung cancer mortality in the 55- to 74-year-old age group by increasing the proportion of cancers detected at an early stage. Because of the increasing life expectancy of the American population, we investigated whether screening for lung cancer might benefit men and women aged 75-84 years. MATERIALS/METHODS:Rates of non-small cell lung cancer (NSCLC) from 2000 to 2009 were calculated in both younger and older age groups using the surveillance epidemiology and end reporting database. OS and lung cancer-specific survival (LCSS) in patients with Stage I NSCLC diagnosed from 2004 to 2009 were analyzed to determine the effects of age and treatment. RESULTS:The per capita incidence of NSCLC decreased in the 55-74 cohort, but increased in the 75-84 cohort over the study period. Crude lung cancer death rates in the two age groups who had no specific treatment were 39.5 and 44.9%, respectively. These rates fell in both age groups when increasingly aggressive treatment was used. Rates of OS and LCSS improved significantly with increasingly aggressive treatment in the 75-84 age group. The survival benefits of increasingly aggressive treatment in 75- to 84-year-old females did not differ from their counterparts in the younger cohort. CONCLUSION:Screening for lung cancer might be of benefit to individuals at increased risk of lung cancer in the 75-84 age group. The survival benefits of aggressive therapy are similar in females between 55-74 and 75-84 years old.


Front Oncol


Frontiers in oncology


Varlotto JM,Decamp MM,Flickinger JC,Lake J,Recht A,Belani CP,Reed MF,Toth JW,Mackley HB,Sciamanna CN,Lipton A,Ali SM,Mahraj RP,Gilbert CR,Yao N




Has Abstract


2014-03-07 00:00:00








  • Lipoxin-Induced Phenotypic Changes in CD115+LY6Chi Monocytes TAM Precursors Inhibits Tumor Development.

    abstract::During tumor development, the spleen acts as an extra-medullar reservoir of LY6Chi inflammatory monocytes, which can migrate toward tumor to differentiate into tumor-associated macrophage (TAMs), renewing the TAM population. In the tumor microenvironment, pro-inflammatory macrophages (M1) acquire anti-inflammatory and...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: de-Brito NM,da-Costa HC,Simões RL,Barja-Fidalgo C

    更新日期:2019-06-19 00:00:00

  • The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy.

    abstract::Esophageal adenocarcinoma (EAC) is a lethal cancer requiring improved screening strategies and treatment options due to poor detection methods, aggressive progression, and therapeutic resistance. Emerging circulating tumor DNA (ctDNA) technologies may offer a unique non-invasive strategy to better characterize the hig...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章,评审


    authors: Kosovec JE,Zaidi AH,Pounardjian TS,Jobe BA

    更新日期:2018-12-11 00:00:00

  • Biomarkers for Immune Checkpoint Inhibitors in Melanoma.

    abstract::Immune checkpoint inhibitors have now become a standard therapy for malignant melanoma. However, as immunotherapies are effective in only a limited number of patients, biomarker development remains one of the most important clinical challenges. Biomarkers predicting clinical benefit facilitate appropriate selection of...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章,评审


    authors: Kitano S,Nakayama T,Yamashita M

    更新日期:2018-07-18 00:00:00

  • Structural Characterization of Mucin O-Glycosylation May Provide Important Information to Help Prevent Colorectal Tumor Recurrence.

    abstract::Although colorectal cancer is a preventable and curable disease if early stage tumors are removed, it still represents the second cause of cancer-related death worldwide. Surgical resection is the only curative treatment but once operated the patient is either subjected to adjuvant chemotherapy or not, depending on th...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Mihalache A,Delplanque JF,Ringot-Destrez B,Wavelet C,Gosset P,Nunes B,Groux-Degroote S,Léonard R,Robbe-Masselot C

    更新日期:2015-10-08 00:00:00

  • Triple-Negative Breast Cancer Comparison With Canine Mammary Tumors From Light Microscopy to Molecular Pathology.

    abstract::Many similar characteristics in human and dog cancers including, spontaneous development, clinical presentation, tumor heterogeneity, disease progression, and response to standard therapies have promoted the approval of this comparative model as an alternative to mice. Breast cancer represents the second most frequent...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章,评审


    authors: Amirkhani Namagerdi A,d'Angelo D,Ciani F,Iannuzzi CA,Napolitano F,Avallone L,De Laurentiis M,Giordano A

    更新日期:2020-11-12 00:00:00

  • Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg?

    abstract::Tumor-induced angiogenesis has been a significant focus of anti-cancer therapies for several decades. The immature and "leaky" tumor vasculature leads to significant cancer cell intravasation, increasing the metastatic potential, while the disoriented and hypo-perfused tumor vessels hamper the anti-tumor efficacy of i...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章,评审


    authors: Mattheolabakis G,Mikelis CM

    更新日期:2019-11-12 00:00:00

  • Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma.

    abstract::Epstein-Barr virus (EBV) establishes lifelong latent infection in humans and is associated with several lymphoid and epithelial cancers. In nasopharyngeal carcinoma (NPC), EBV expresses few viral proteins but elevated levels of Bam-HI A rightward transcripts (BARTs) RNA, which includes viral microRNAs and long non-cod...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Verhoeven RJA,Tong S,Mok BW,Liu J,He S,Zong J,Chen Y,Tsao SW,Lung ML,Chen H

    更新日期:2019-10-22 00:00:00

  • Credentialing for participation in clinical trials.

    abstract::The National Cancer Institute (NCI) clinical cooperative groups have been instrumental over the past 50 years in developing clinical trials and evidence-based clinical trial processes for improvements in patient care. The cooperative groups are undergoing a transformation process to launch, conduct, and publish clinic...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Followill DS,Urie M,Galvin JM,Ulin K,Xiao Y,Fitzgerald TJ

    更新日期:2012-12-26 00:00:00

  • Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium.

    abstract::Background: Stabilized mutant p53 protein (mutp53) is a novel target in epithelial ovarian cancer. Due to aberrant conformation, mutp53 proteins depend on folding support by the Hsp90 chaperone. Hsp90 blockade induces degradation of mutp53, resulting in tumor cell cytotoxicity and increased sensitivity to chemotherape...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Ray-Coquard I,Braicu I,Berger R,Mahner S,Sehouli J,Pujade-Lauraine E,Cassier PA,Moll UM,Ulmer H,Leunen K,Zeimet AG,Marth C,Vergote I,Concin N

    更新日期:2019-09-10 00:00:00

  • The emerging role of d-2-hydroxyglutarate as an oncometabolite in hematolymphoid and central nervous system neoplasms.

    abstract::Approximately 20% of unselected cases and 30% cytogenetically diploid cases of acute myeloid leukemia (AML) and 80% of grade II-III gliomas and secondary glioblastomas carry mutations in the isocitrate dehydrogenase (IDH) 1 and 2 genes. IDH1/2 mutations prevent oxidative decarboxylation of isocitrate to α-ketoglutarat...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Rakheja D,Medeiros LJ,Bevan S,Chen W

    更新日期:2013-07-02 00:00:00

  • Changes in Tumor-Infiltrating Lymphocytes and Vascular Normalization in Breast Cancer Patients After Neoadjuvant Chemotherapy and Their Correlations With DFS.

    abstract::Objective: Changes in the number of various tumor-infiltrating lymphocytes (TILs) and degrees of vascular normalization in breast cancer (BC) patients after neoadjuvant chemotherapy (NAC) were analyzed to screen key factors that can predict the prognosis. Methods: HE-stained sections were used to assess the degree of ...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Wang Q,Xiang Q,Yu L,Hu T,Chen Y,Wang J,Nie X,Cheng J

    更新日期:2020-01-22 00:00:00

  • The Significance of the CLDN18-ARHGAP Fusion Gene in Gastric Cancer: A Systematic Review and Meta-Analysis.

    abstract::Objective: The objective of this study was to summarize the clinicopathological characteristics of the CLDN18-ARHGAP fusion gene in gastric cancer patients. Background: The CLDN18-ARHGAP26 fusion gene is one of the most frequent somatic genomic rearrangements in gastric cancer, especially in the genomically stable (GS...

    journal_title:Frontiers in oncology



    authors: Zhang WH,Zhang SY,Hou QQ,Qin Y,Chen XZ,Zhou ZG,Shu Y,Xu H,Hu JK

    更新日期:2020-09-02 00:00:00

  • NAP1L1: A Novel Human Colorectal Cancer Biomarker Derived From Animal Models of Apc Inactivation.

    abstract:Introduction:Colorectal cancer (CRC) is the second leading cause of cancer death worldwide and most deaths result from metastases. We have analyzed animal models in which Apc, a gene that is frequently mutated during the early stages of colorectal carcinogenesis, was inactivated and human samples to try to identify nov...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Queiroz CJS,Song F,Reed KR,Al-Khafaji N,Clarke AR,Vimalachandran D,Miyajima F,Pritchard DM,Jenkins JR

    更新日期:2020-08-11 00:00:00

  • HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease.

    abstract::Retroviruses that have the ability to infect germ line cells can become an integral and inherited part of the host genome. About 8% of the human chromosomal DNA consists of sequences derived from infections by retroviruses that presumably circulated 2-40 millions of years ago, and some elements are actually much older...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章,评审


    authors: Hohn O,Hanke K,Bannert N

    更新日期:2013-09-20 00:00:00

  • Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study.

    abstract::Background: Pediatric neurofibromatosis type 1 (NF1) patients rarely develop aggressive central nervous system tumors. Among high-grade gliomas (HGGs), histone mutant diffuse midline gliomas (DMGs H3 K27M-mutant) have exceptionally been reported. The aim of this retrospectives single-center study was to compare the cl...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Garibotto F,Madia F,Milanaccio C,Verrico A,Piccardo A,Tortora D,Piatelli G,Diana MC,Capra V,Garrè ML,Rossi A,Morana G

    更新日期:2020-06-03 00:00:00

  • Phosphoproteomic Analysis of Cell-Based Resistance to BRAF Inhibitor Therapy in Melanoma.

    abstract::The treatment of melanoma by targeted inhibition of the mutated kinase BRAF with small molecules only temporarily suppresses metastatic disease. In the face of chemical inhibition tumor plasticity, both innate and adaptive, promotes survival through the biochemical and genetic reconfiguration of cellular pathways that...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Parker R,Vella LJ,Xavier D,Amirkhani A,Parker J,Cebon J,Molloy MP

    更新日期:2015-05-15 00:00:00

  • Mechanisms of Cancer Resistance to Immunotherapy.

    abstract::Over the last decade, based on the extensive development of preclinical animal studies and clinical trials, the efficacy, and mechanisms of immunotherapy have been fully explored. Significant and lasting clinical responses with immunotherapy provide a new breakthrough treatment for a variety of refractory cancer histo...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章,评审


    authors: Bai R,Chen N,Li L,Du N,Bai L,Lv Z,Tian H,Cui J

    更新日期:2020-08-06 00:00:00

  • Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience.

    abstract:PURPOSE/OBJECTIVES:Stereotactic body radiation therapy (SBRT) is emerging as a minimally invasive alternative to brachytherapy to deliver highly conformal, dose--escalated radiation therapy (RT) to the prostate. SBRT alone may not adequately cover the tumor extensions outside the prostate commonly seen in unfavorable p...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Mercado C,Kress MA,Cyr RA,Chen LN,Yung TM,Bullock EG,Lei S,Collins BT,Satinsky AN,Harter KW,Suy S,Dritschilo A,Lynch JH,Collins SP

    更新日期:2016-05-06 00:00:00

  • Hyperspectral Imaging as an Early Biomarker for Radiation Exposure and Microcirculatory Damage.

    abstract:BACKGROUND:Radiation exposure can lead to detrimental effects in skin microcirculation. The precise relationship between radiation dose received and its effect on cutaneous perfusion still remains controversial. Previously, we have shown that hyperspectral imaging (HSI) is able to demonstrate long-term reductions in cu...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Chin MS,Freniere BB,Lancerotto L,Lujan-Hernandez J,Saleeby JH,Lo YC,Orgill DP,Lalikos JF,Fitzgerald TJ

    更新日期:2015-10-26 00:00:00

  • Spectrum of Mesenchymal-Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis.

    abstract:Background:The receptor tyrosine kinase mesenchymal-epithelial transition factor (MET) is frequently altered in cancers and is a common therapeutic target for cancers with MET variants. However, abnormal MET alterations and their associations with patient outcome across different cancer types have not been studied simu...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Li J,Hu K,Zhou L,Huang J,Zeng S,Xu Z,Yan Y

    更新日期:2020-10-15 00:00:00

  • Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting.

    abstract:BACKGROUND:Whole-brain radiation therapy (WBRT), stereotactic radiosurgery (SRS), or both are commonly employed in the treatment of limited brain metastases in the initial or recurrent setting. Hypofractionated partial volume irradiation is also employed, however, published experience using helical TomoTherapy (HT) for...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Elson A,Walker A,Bovi JA,Schultz C

    更新日期:2015-02-09 00:00:00

  • P62/Ubiquitin IHC Expression Correlated with Clinicopathologic Parameters and Outcome in Gastrointestinal Carcinomas.

    abstract::P62 and ubiquitin are small regulatory proteins demonstrated to have implications in the prognosis and survival of various malignancies including: hepatocellular, breast, ovarian, and some gastrointestinal carcinomas. Several trials studied the link of their activity to the extrinsic apoptosis pathway and showed that ...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Mohamed A,Ayman A,Deniece J,Wang T,Kovach C,Siddiqui MT,Cohen C

    更新日期:2015-03-30 00:00:00

  • Correlation Patterns Among B7 Family Ligands and Tryptophan Degrading Enzymes in Hepatocellular Carcinoma.

    abstract::Mechanisms of dysfunctional T cell immunity in Hepatocellular Carcinoma (HCC) need to be well defined. B7 family molecules provide both co-stimulatory and co-inhibitory signals to T cells while tryptophan degrading enzymes like Indoleamine 2,3 dioxygenase (IDO) and Tryptophan 2,3 Dioxygenase (TDO) mediate tumor immune...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Chinnadurai R,Scandolara R,Alese OB,Arafat D,Ravindranathan D,Farris AB,El-Rayes BF,Gibson G

    更新日期:2020-09-03 00:00:00

  • LRRC4 Suppresses E-Cadherin-Dependent Collective Cell Invasion and Metastasis in Epithelial Ovarian Cancer.

    abstract::Epithelial ovarian cancer (EOC) is the most malignant gynecological carcinoma and is of a high incidence of death due to detection at late stages when metastasis already occurs. However, the mechanism underlying metastasis of EOC remains unclear. Analysis of the open database and experiments with immunochemistry showe...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Zhao C,She X,Zhang Y,Liu C,Li P,Chen S,Sai B,Li Y,Feng J,Liu J,Sun Y,Xiao S,Li L,Wu M

    更新日期:2020-02-14 00:00:00

  • Glycosylated Notch and Cancer.

    abstract::Glycosylation is one of the key components influencing several signaling pathways implicated in cell survival and growth. The Notch signaling pathway plays a pivotal role in numerous cell fate specifications during metazoan development. Both Notch and its ligands are repeatedly glycosylated by the addition of sugar mo...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章,评审


    authors: Pakkiriswami S,Couto A,Nagarajan U,Georgiou M

    更新日期:2016-02-18 00:00:00

  • Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer Patients.

    abstract::Breast cancer is the most common cancer in women worldwide. Elucidation of underlying biology and molecular pathways is necessary for improving therapeutic options and clinical outcomes. CLN3 protein (CLN3p), deficient in neurodegenerative CLN3 disease is anti-apoptotic, and defects in the CLN3 gene cause accelerated ...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Makoukji J,Raad M,Genadry K,El-Sitt S,Makhoul NJ,Saad Aldin E,Nohra E,Jabbour M,Sangaralingam A,Chelala C,Habib RH,Boulos F,Tfayli A,Boustany RM

    更新日期:2015-10-12 00:00:00

  • The Role of an Integrated Multidisciplinary Clinic in the Management of Patients with Cutaneous Lymphoma.

    abstract::The clinical benefit of a multidisciplinary clinic practice model has been well described in a variety of medical specialties and cancer types. It proves particularly valuable when an integrated team is needed to optimally manage patients with rare or complex neoplasms. However, the ideal implementation of an integrat...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章,评审


    authors: Tyler KH,Haverkos BM,Hastings J,Hu E,Philips R,Gru AA,Welliver MX,Mishra A,Wong HK,Porcu P

    更新日期:2015-06-17 00:00:00

  • AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.

    abstract::AUNIP, a novel prognostic biomarker, has been shown to be associated with stromal and immune scores in oral squamous cell carcinoma (OSCC). Nonetheless, its role in other cancer types was unclear. In this study, AUNIP expression was increased in hepatocellular carcinoma (HCC) and lung adenocarcinoma (LUAD) according t...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Ma C,Kang W,Yu L,Yang Z,Ding T

    更新日期:2020-12-09 00:00:00

  • The utility of positron emission tomography in the treatment planning of image-guided radiotherapy for non-small cell lung cancer.

    abstract::In the thorax, the extent of tumor may be more accurately defined with the addition of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) to computed tomography (CT). This led to the increased utility of FDG-PET or PET/CT in the treatment planning of radiotherapy for non-small cell lung cancer (NSCLC). ...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章,评审


    authors: Chi A,Nguyen NP

    更新日期:2014-10-07 00:00:00

  • NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype.

    abstract::Metastasis remains the cause of over 90% of cancer-related deaths. Cells undergoing metastasis use phenotypic plasticity to adapt to their changing environmental conditions and avoid therapy and immune response. Reversible transitions between epithelial and mesenchymal phenotypes - epithelial-mesenchymal transition (E...

    journal_title:Frontiers in oncology

    pub_type: 杂志文章


    authors: Subbalakshmi AR,Kundnani D,Biswas K,Ghosh A,Hanash SM,Tripathi SC,Jolly MK

    更新日期:2020-09-08 00:00:00